Boldine prevents diabetes-induced skeletal muscle dysfunction by inhibiting large-pore channels

This study demonstrates that boldine, an alkaloid from *Peumus boldus*, prevents diabetes-induced skeletal muscle dysfunction, lipid accumulation, and inflammation in mice and human myoblasts by inhibiting large-pore channel activity and subsequently suppressing calcium-dependent inflammasome activation and adipogenic pathways.

The Gist

The Big Picture: Diabetes and the "Rusty" Muscle

Imagine your body's muscles as a high-performance factory. In a healthy body, this factory runs smoothly, turning sugar (glucose) into energy to keep you strong and moving.

But when someone has diabetes, there is too much sugar floating around in the bloodstream. Think of this excess sugar like sticky, corrosive sludge that gets everywhere. Over time, this sludge damages the factory floor. The machines (muscle fibers) start to rust, the workers (cells) get confused, and the factory starts filling up with trash (fat) instead of producing energy. This leads to weak muscles, poor blood flow, and inflammation.

This study asks a simple question: Can we clean up the factory and fix the machines? The researchers tested a natural substance called Boldine (found in the Boldo tree in Chile) to see if it could stop this damage.

---

The Culprit: The "Broken Windows" (Large-Pore Channels)

To understand how Boldine works, we need to look at the "windows" on the muscle cells.

• Normal Cells: Have tiny, secure windows that only let specific things in and out.
• Diabetic Cells: The high sugar levels cause these windows to get stuck wide open. These are called "large-pore channels."

What happens when the windows are stuck open?

1. The Leak: Important stuff leaks out, and bad stuff (like calcium and inflammatory signals) leaks in.
2. The Confusion: The cell gets confused. Instead of staying a muscle cell, it starts acting like a fat cell.
3. The Chaos: The open windows trigger an alarm system (inflammation) that makes the muscle sore and weak.

The Hero: Boldine as the "Window Lock"

Boldine acts like a master key or a heavy-duty lock. When the researchers gave Boldine to diabetic mice, it didn't just clean the sludge; it physically locked those broken windows shut.

Here is what happened when the windows were locked:

1. The Factory Got Strong Again (Muscle Strength)

• Before: The diabetic mice had weak muscles, like a car with a flat tire. They couldn't grip things well.
• After: Once Boldine locked the windows, the mice's grip strength returned to normal. The "rust" on the machines was stopped.

2. The Power Lines Were Fixed (Blood Flow)

• Before: Diabetes damaged the tiny blood vessels (capillaries) feeding the muscle, like clogged pipes. The muscle wasn't getting enough oxygen or nutrients.
• After: Boldine helped rebuild these pipes. The blood flow returned, and the muscle could breathe again.

3. The Trash Was Stopped (Lipid Accumulation)

• Before: Because the cells were confused by the open windows, they started turning into fat cells. The muscle fibers were filling up with oil droplets (like a sponge soaked in grease).
• After: With the windows locked, the cells remembered how to be muscle cells. The fat accumulation stopped, and the muscle stayed lean.

4. The Fire Alarm Was Silenced (Inflammation)

• Before: The open windows set off a fire alarm (the NLRP3 inflammasome), causing constant inflammation and pain.
• After: Locking the windows turned off the alarm. The levels of inflammatory signals dropped significantly.

---

How It Works: The Chain Reaction

The researchers figured out the exact chain of events that Boldine stops:

1. High Sugar hits the muscle cell.
2. Windows Open: The "large-pore channels" (Connexins) open up.
3. Calcium Rush: Calcium floods the cell like water through a burst pipe.
4. The Alarm: This calcium rush triggers the inflammation alarm and tells the cell to turn into fat.
5. Boldine Intervenes: It blocks the windows before the water floods in. No flood means no alarm, and no confusion means the cell stays a muscle.

The Bottom Line

This study shows that Boldine is a powerful tool against diabetes-related muscle weakness. It works by acting as a security guard that closes the broken windows on muscle cells, preventing the sugar from causing chaos.

Why does this matter?
Currently, there isn't a perfect cure for the muscle weakness caused by diabetes. This research suggests that targeting these "broken windows" could be a new way to keep muscles strong, reduce fat in the muscles, and lower inflammation in people with diabetes. It's like finding a way to repair the factory floor so the workers can get back to doing their job.

Technical Summary

1. Problem Statement

Diabetes mellitus (DM) causes significant skeletal muscle myopathy (SMM), characterized by muscle atrophy, loss of strength, impaired blood perfusion, lipid accumulation (intramuscular fat), and chronic inflammation. A critical, yet poorly understood, mechanism involves the aberrant differentiation of muscle progenitor cells (satellite cells/myoblasts) toward an adipogenic lineage rather than a myogenic one under high-glucose conditions.

The authors hypothesize that large-pore channels (specifically hemichannels formed by Connexins and Pannexin1) are central drivers of this pathology. Under hyperglycemic stress, these channels open excessively, increasing membrane permeability, triggering calcium influx, inflammasome activation, and oxidative stress, ultimately leading to muscle dysfunction and fat infiltration. The study investigates whether Boldine, an alkaloid from Peumus boldus known to block these channels, can prevent these diabetic myopathy features.

2. Methodology

The study employed a dual approach: in vivo animal models and in vitro human cell cultures.

A. In Vivo Model (Mouse)

• Subjects: Male C57BL/6J mice.
• Induction: Diabetes was induced via intraperitoneal Streptozotocin (STZ) injections (40 mg/kg/day for 5 days).
• Treatment: Diabetic mice were treated orally with Boldine (50 mg/kg/day) for 4 weeks. Control groups included healthy mice and diabetic mice receiving a vehicle (peanut butter).
• Assessments:
  • Muscle Strength: Forelimb grip strength measured via digital force transducer.
  • Membrane Physiology: Resting Membrane Potential (RMP) recorded from isolated flexor digitorum brevis (FDB) myofibers using whole-cell patch-clamp.
  • Vascular Function: In vivo blood perfusion in the gastrocnemius muscle measured via Laser Speckle Contrast Imaging (LSCI) at baseline and after acetylcholine (ACh) stimulation.
  • Histology & Molecular: Oil Red O staining for lipid accumulation; CD31 immunofluorescence for capillary density; qPCR for NLRP3 mRNA levels.

B. In Vitro Model (Human Myoblasts)

• Cell Line: Human myoblasts (AB1167).
• Conditions: Cultured in Low Glucose (LG, 8 mM) vs. High Glucose (HG, 25 mM) with or without Boldine (50 µM). Differentiation was induced with horse serum.
• Assessments:
  • Membrane Permeability: Ethidium bromide (Etd⁺) uptake assay to measure large-pore channel activity.
  • Signaling Pathways: Intracellular Ca²⁺ (Fura-2), Nitric Oxide (NO) production (DAF-FM), and PPARγ nuclear localization (Immunofluorescence).
  • Pharmacology: Use of specific inhibitors (D4 for Cx43/45, A740003 for P2X7R, SB203580 for p38 MAPK, MRS2179 for P2Y1, BAPTA-AM for Ca²⁺ chelation, DTT for redox modulation) to dissect the mechanism.
  • Gene Expression: qPCR for NLRP3 and Caspase-1.

3. Key Contributions

• Mechanistic Link: Establishes a direct causal link between hyperglycemia-induced large-pore channel (hemichannel) opening and the triad of muscle weakness, lipid accumulation, and inflammation in diabetes.
• Therapeutic Validation: Demonstrates that Boldine acts as a potent therapeutic agent that reverses multiple pathological hallmarks of diabetic myopathy, not just by antioxidant effects but specifically through channel blockade.
• Differentiation Fate: Identifies that high glucose drives myoblasts toward adipogenic differentiation (via PPARγ activation) via a large-pore channel-dependent pathway, which Boldine successfully blocks.
• Vascular Protection: Reveals that Boldine preserves microvascular density and endothelial-dependent vasodilation in diabetic muscle, addressing the perfusion deficit associated with SMM.

4. Key Results

A. Functional and Physiological Improvements (In Vivo)

• Strength & Excitability: STZ mice showed reduced grip strength and depolarized RMP. Boldine treatment fully restored both to control levels.
• Perfusion: Diabetic mice had ~20% lower basal perfusion and a blunted response to acetylcholine (endothelial dysfunction). Boldine preserved basal perfusion and restored ACh-induced vasodilation.
• Angiogenesis: Diabetes reduced capillary density (CD31⁺/fiber ratio); Boldine treatment significantly restored capillary density.

B. Metabolic and Inflammatory Markers

• Lipid Accumulation: Diabetic muscle showed massive lipid infiltration (52.4% Oil Red O⁺ fibers). Boldine reduced this to near-control levels (15.2%).
• Inflammasome: NLRP3 mRNA was upregulated ~17-fold in diabetic muscle. Boldine reduced this by ~50% (though levels remained higher than controls).
• In Vitro Confirmation: In human myoblasts, HG increased Etd⁺ uptake (permeability), intracellular Ca²⁺, NO production, and NLRP3/Caspase-1 expression. Boldine prevented all these changes.

C. Molecular Mechanism of Action

• Channel Identity: The HG-induced increase in permeability was mediated primarily by Connexin hemichannels (Cx43/Cx45) and P2X7 receptors, as specific blockers (D4, A740003) abolished the effect. Panx1 channels played a minor role.
• Signaling Cascade:
  1. HG increases intracellular Ca²⁺ and NO.
  2. NO causes S-nitrosylation of Cx43, increasing channel open probability.
  3. p38 MAPK signaling is also involved.
  4. This leads to a positive feedback loop (ATP release $\to$ P2X7 activation $\to$ more Ca²⁺).
• Adipogenic Drift: HG caused ~45% of myoblast nuclei to express PPARγ (adipogenic marker) and accumulate lipid droplets. Boldine blocked this nuclear translocation and lipid accumulation.

5. Significance and Conclusion

This study provides a comprehensive mechanistic framework for diabetic skeletal muscle dysfunction, positioning large-pore channel hyperactivity as a unifying driver of muscle weakness, metabolic derangement (lipid accumulation), and inflammation.

• Clinical Relevance: The findings suggest that targeting hemichannels is a viable therapeutic strategy for diabetic myopathy. Boldine, with its dual action of blocking hemichannels and possessing antioxidant properties, emerges as a promising disease-modifying candidate.
• Broader Impact: The mechanism identified (hemichannel-mediated shift from myogenic to adipogenic differentiation) may apply to other muscle pathologies involving metabolic stress, such as obesity, dysferlinopathy, and Duchenne muscular dystrophy.
• Future Directions: The study supports further investigation into hemichannel blockers as a class of drugs for treating metabolic myopathies and highlights the importance of preserving microvascular integrity in diabetic muscle.

Limitations noted in the text: The study is a preprint (not yet peer-reviewed), and while Boldine significantly reduced NLRP3 expression, it did not fully normalize it to control levels, suggesting additional pathways may be involved.